CD163-expressing TAMs displayed elevated levels of pSTAT3 and correlated to poor prognosis in 77 patients with myeloma from STAT3 is over-activated within CD163pos bone marrow macrophages in both Multiple Myeloma and the benign pre-condition MGUS (60). This evidence concerns the gene STAT3 and plasma cell myeloma.